JUN 20, 2018 6:00 AM PDT

Standardized Precision Medicine? - A Quality Management Perspective on NGS-based Individualized Therapies

Speaker
  • Independent Freelancer
    Biography
      Christoph Endrullat is an independent freelancer in the life science and healthcare sector. Beforehand he held positions as a key account manager for oncology at Merck/EMD Group and as a scientific staff member in the Molecular Biotechnology and Functional Genomics division of the Technical University of Applied Sciences Wildau. His research interest and current expertise relies on next-generation sequencing (NGS) in association with precision medicine with a special focus on standardization and quality management. Especially, his efforts in the development and establishment of standards for NGS with the promising application in clinical oncology/precision medicine led to several delegations in authorities and projects. The ISO/TC 276 'Biotechnology', an expert group of the European Commission (JRC) as well as the COST Action CHARME represent his recent affiliations. His academic career comprised a Master of Science in Biotechnology from the University of Glasgow (UK) and a Bachelor of Science in Biosystems Technology/Bioinformatics from the Technical University of Applied Sciences Wildau (Germany). Further, he has published different scientific papers and gave presentations on diverse conferences and workshops.

    Abstract

    Precision medicine and next-generation sequencing – Two terms characterized by a highly dynamic nature, strong innovations and a bright future. Both merged together will exert a decisive influence on academia, industry and the clinical environment. However, both are still facing several challenges and to do’s, which will need to be addressed in order to receive a standard status in the healthcare sector. Beginning with general problems like physicians awareness, novel clinical study designs as well as refunding policies and regulatory issues, the NGS upstream pipeline exhibits additional pitfalls such as quality of FFPE samples, missing standards and restrictive guidelines as well as biomarker validation and certification concerns. The data landscape represents an adjunct construction site, covering questions about the implementation of quality assured data, possible benchmarks, SOP’s, minimum requirements for quality metrics and final data storage considerations. The presentation will shine a light on those obstacles and will provide suggestions on how to possibly overcome them in order to pave the way for reliable, traceable and reproducible results within a standardized environment.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    Loading Comments...
    Show Resources
    Attendees
    • See more